Combined targeting of AKT and mTOR using MK-2206 and RAD001 is synergistic in the treatment of cholangiocarcinoma (Q39165973)
Jump to navigation
Jump to search
scientific article published on 29 May 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | Combined targeting of AKT and mTOR using MK-2206 and RAD001 is synergistic in the treatment of cholangiocarcinoma |
scientific article published on 29 May 2013 |
Statements
1 reference
Combined targeting of AKT and mTOR using MK-2206 and RAD001 is synergistic in the treatment of cholangiocarcinoma (English)
1 reference
Florian Ewald
1 reference
Nicole Grabinski
1 reference
Astrid Grottke
1 reference
Sabine Windhorst
1 reference
Dominik Nörz
1 reference
Lisa Carstensen
1 reference
Katharina Staufer
1 reference
Bianca T Hofmann
1 reference
Frank Diehl
1 reference
Kerstin David
1 reference
Udo Schumacher
1 reference
Björn Nashan
1 reference
Manfred Jücker
1 reference
29 May 2013
1 reference
1 reference
133
1 reference
9
1 reference
2065-2076
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference